Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
6,190
Ticker
1801
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Innovent Biologics Waste Data Preview

In 2023, Innovent Biologics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023202220212020 - 2017
Total Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Innovent Biologics's Waste Management data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Innovent Biologics’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Innovent Biologics’s data sources below and access millions more through our Disclosure Search.

a. Innovent Biologics's ESG Report 2023
Trace every data point back to Innovent Biologics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Innovent Biologics’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Innovent Biologics generated a total of 693 metric tonnes of waste. a

Of this amount, 67.09% of Innovent Biologics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 32.91% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. a

Innovent Biologics’s Hazardous vs Non-Hazardous Waste Over Time

202220230200400600800tonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Innovent Biologics reduced the environmental impact of its waste?

Since 2023, Innovent Biologics's total waste generation has increased by 41.6%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts. a

Since 2023, Innovent Biologics's hazardous waste generation has increased by 32.91%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies.. a

Overall, Innovent Biologics's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy. a

Want Full Access to Innovent Biologics's Waste Management Dataset?
Sign Up